This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Eli Lilly and Company. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Dariusz Stanislaw Wodka: Innovator in Pharmaceutical Chemistry
Introduction
Dariusz Stanislaw Wodka is a notable inventor based in Zionsville, Indiana. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that address critical health issues.
Latest Patents
Wodka holds a patent for "Condensed thiophene derivatives useful as NaPi-IIb inhibitors." This invention provides compounds of a specific formula, along with pharmaceutically acceptable salts and pharmaceutical compositions. These compounds are designed to treat hyperphosphatemia, chronic kidney disease, and cardiovascular diseases associated with chronic kidney disease. He has 1 patent to his name.
Career Highlights
Dariusz Wodka is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. His work focuses on innovative solutions that enhance patient care and treatment outcomes.
Collaborations
Wodka collaborates with esteemed colleagues, including David Andrew Coates and Kevin Robert Fales, contributing to a dynamic research environment that fosters innovation.
Conclusion
Dariusz Stanislaw Wodka exemplifies the spirit of innovation in the pharmaceutical industry, with his work paving the way for advancements in treating serious health conditions. His contributions are vital to improving patient health and well-being.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile